Kymera Therapeutics (KYMR) Cash & Equivalents (2019 - 2026)
Kymera Therapeutics' Cash & Equivalents came in at $124.48 million for Q2 2026, down 62.9% from $335.82 million a year earlier and down 13.6% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Kymera Therapeutics' Cash & Equivalents was $357.01 million, up 196.9% from FY2024.
- Cash & Equivalents has increased in each of the last five years, with a five-year compound annual growth rate of 63.0% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $120.26 million in FY2024 (+9.4%), $109.97 million in FY2023 (+60.8%), $68.4 million in FY2022 (+42.6%) and $47.98 million in FY2021 (+54.7%).
- The five-year range for quarterly Cash & Equivalents is $33.73 million (Q1 2022) to $357.01 million (Q4 2025).
- Year-over-year, Cash & Equivalents increased in six of the last eight quarters, with growth averaging 79.4%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2025 (growth of 396.7%), and the weakest in Q2 2026 (a decline of 62.9%).
- Business Quant data shows KYMR's Cash & Equivalents at $144.09 million (Q1 2026), $357.01 million (Q4 2025) and $112.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Kymera Therapeutics | 8.89 Bn | 6.19 Bn | - | 124.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124.48 Mn |
| Mar 31, 2026 | 144.09 Mn |
| Dec 31, 2025 | 357.01 Mn |
| Sep 30, 2025 | 112.95 Mn |
| Jun 30, 2025 | 335.82 Mn |
| Mar 31, 2025 | 89.97 Mn |
| Dec 31, 2024 | 120.26 Mn |
| Sep 30, 2024 | 110.72 Mn |
| Jun 30, 2024 | 67.61 Mn |
| Mar 31, 2024 | 93.51 Mn |
| Dec 31, 2023 | 109.97 Mn |
| Sep 30, 2023 | 81.05 Mn |
| Jun 30, 2023 | 52.39 Mn |
| Mar 31, 2023 | 50.15 Mn |
| Dec 31, 2022 | 68.40 Mn |
| Sep 30, 2022 | 155.66 Mn |
| Jun 30, 2022 | 76.91 Mn |
| Mar 31, 2022 | 33.73 Mn |
| Dec 31, 2021 | 47.98 Mn |
| Sep 30, 2021 | 156.82 Mn |
API Access
Kymera Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();